Jose Trevejo
Equibles does not estimate personal net worth.
About Jose Trevejo
Tarsus Pharmaceuticals, Inc. reported in an 8-K filed January 18, 2024 that Jose Trevejo resigned as Chief Medical Officer, effective January 18, 2024. The proxy statement of Tarsus Pharmaceuticals, Inc. reports total compensation of $3,017,791 for Jose Trevejo in fiscal 2022, including a base salary of $403,333.
“On January 18, 2024, Tarsus Pharmaceuticals, Inc. (the “Company”) announced that Jose Trevejo, M.D., Ph.D. would be leaving his role as the Company’s Chief Medical Officer (the “Transition”), effective as of January 18, 2024 (the “Transition Date”), and leaving his employment with the Company on February 17, 2024.”
Affiliation history
-
Tarsus Pharmaceuticals, Inc. (TARS)
Proxy statement
Start not stated–2024-01-18
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Tarsus Pharmaceuticals, Inc. (TARS) | M.D., Ph.D Chief Medical Officer | $403,333 | $3,017,791 |